Sfoglia per Autore
Triglyceride-glucose Index and Mortality in a Large Regional-based Italian Database (Urrah Project)
2024 D'Elia, L; Masulli, M; Virdis, A; Casiglia, E; Tikhonoff, V; Angeli, F; Barbagallo, C; Bombelli, M; Cappelli, F; Cianci, R; Ciccarelli, M; Cicero, A; Cirillo, M; Cirillo, P; Dell'Oro, R; Desideri, G; Ferri, C; Gesualdo, L; Giannattasio, C; Grassi, G; Iaccarino, G; Lippa, L; Mallamaci, F; Maloberti, A; Masi, S; Mazza, A; Mengozzi, A; Muiesan, M; Nazzaro, P; Palatini, P; Parati, G; Pontremoli, R; Quarti-Trevano, F; Rattazzi, M; Reboldi, G; Rivasi, G; Russo, E; Salvetti, M; Tocci, G; Ungar, A; Verdecchia, P; Viazzi, F; Volpe, M; Borghi, C; Galletti, F
Mechanisms of Vascular Inflammation and Potential Therapeutic Targets: A Position Paper From the ESH Working Group on Small Arteries
2024 Rios, F; de Ciuceis, C; Georgiopoulos, G; Lazaridis, A; Nosalski, R; Pavlidis, G; Tual-Chalot, S; Agabiti-Rosei, C; Camargo, L; Dąbrowska, E; Quarti-Trevano, F; Hellmann, M; Masi, S; Lopreiato, M; Mavraganis, G; Mengozzi, A; Montezano, A; Stavropoulos, K; Winklewski, P; Wolf, J; Costantino, S; Doumas, M; Gkaliagkousi, E; Grassi, G; Guzik, T; Ikonomidis, I; Narkiewicz, K; Paneni, F; Rizzoni, D; Stamatelopoulos, K; Stellos, K; Taddei, S; Touyz, R; Virdis, A
Devices-based treatment of hypertension: the position of the European Society of Hypertension (ESH) 2023 guidelines
2024 Grassi, G
Rationale of the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines
2024 Mancia, G; Brunström, M; Burnier, M; Grassi, G; Januszewicz, A; Kjeldsen, S; Muiesan, M; Thomopoulos, C; Tsioufis, K; Kreutz, R
Regional and temporal differences in the associations between cardiovascular disease and its classic risk factors: an analysis of 49 cohorts from 11 European countries
2024 Reinikainen, J; Kuulasmaa, K; Oskarsson, V; Amouyel, P; Biasch, K; Brenner, H; De Ponti, R; Donfrancesco, C; Drygas, W; Ferrieres, J; Grassi, G; Grimsgaard, S; Iacoviello, L; Jousilahti, P; Kårhus, L; Kee, F; Linneberg, A; Luksiene, D; Mariño, J; Moitry, M; Palmieri, L; Peters, A; Piwonska, A; Quarti-Trevano, F; Salomaa, V; Sans, S; Schmidt, C; Schöttker, B; Söderberg, S; Tamosiunas, A; Thorand, B; Tunstall-Pedoe, H; Vanuzzo, D; Veronesi, G; Woodward, M; Lekadir, K; Niiranen, T
Italian Society of Interventional Cardiology (GISE) and Italian Society of Arterial Hypertension (SIIA) Position Paper on the role of renal denervation in the management of the difficult-to-treat hypertension
2024 Stabile, E; Muiesan, M; Ribichini, F; Sangiorgi, G; Taddei, S; Versaci, F; Villari, B; Bacca, A; Benedetto, D; Fioretti, V; Laurenzano, E; Scapaticci, M; Saia, F; Tarantini, G; Grassi, G; Esposito, G
Sympathetic overactivity, hypertension and cardiovascular disease: state of the art
2024 Grassi, G; Drager, L
Rationale of treatment recommendations in the 2023 ESH hypertension guidelines
2024 Mancia, G; Brunström, M; Burnier, M; Grassi, G; Januszewicz, A; Muiesan, M; Tsioufis, K; Kjeldsen, S; Kreutz, R
The role of B-Blockers in medical treatment
2024 Kjeldsen, S; Grassi, G
Prognostic Value and Relative Cutoffs of Triglycerides Predicting Cardiovascular Outcome in a Large Regional‐Based Italian Database
2024 Tikhonoff, V; Casiglia, E; Virdis, A; Grassi, G; Angeli, F; Arca, M; Barbagallo, C; Bombelli, M; Cappelli, F; Cianci, R; Cicero, A; Cirillo, M; Cirillo, P; Dell'Oro, R; D'Elia, L; Desideri, G; Ferri, C; Galletti, F; Gesualdo, L; Giannattasio, C; Iaccarino, G; Mallamaci, F; Maloberti, A; Masi, S; Masulli, M; Mazza, A; Mengozzi, A; Muiesan, M; Nazzaro, P; Palatini, P; Parati, G; Pontremoli, R; Quarti-Trevano, F; Rattazzi, M; Reboldi, G; Rivasi, G; Russo, E; Salvetti, M; Temporelli, P; Tocci, G; Ungar, A; Verdecchia, P; Viazzi, F; Volpe, M; Borghi, C
Uric acid and left ventricular hypertrophy: a gender-based meta-analysis of echocardiographic studies
2024 Gherbesi, E; Faggiano, A; Sala, C; Carugo, S; Grassi, G; Tadic, M; Cuspidi, C
Assessment and Management of Patients with Obesity and Hypertension in European Society of Hypertension Excellence Centres. A survey from the ESH Working Group on Diabetes and Metabolic Risk Factors
2024 Antza, C; Grassi, G; Weber, T; Persu, A; Jordan, J; Nilsson, P; Redon, J; Stabouli, S; Kreutz, R; Kotsis, V
Cardio-Ankle Vascular Index As A Marker Of Left Ventricular Hypertrophy In Treated Hypertensives: Findings From The Pamela Study
2024 Cuspidi, C; Facchetti, R; Quarti-Trevano, F; Dell'Oro, R; Mancia, G; Grassi, G
Why were the 2023 Guidelines of the European Society of Hypertension not developed as Joint Guidelines together with the European Society of Cardiology?
2024 Kreutz, R; Azizi, M; Grassi, G; Januszewicz, A; Kahan, T; Lurbe, E; Polonia, J; Tsioufis, K; Weber, T; Williams, B; Mancia, G
New European Guidelines 2023 for Hypertension: When and Why Should We Think About Sleep Apnea?
2024 Grassi, G; Mancia, G
Long-term increase in serum uric acid and its predictors over a 25 year follow-up: Results of the PAMELA study
2024 Maloberti, A; Dell'Oro, R; Bombelli, M; Quarti-Trevano, F; Facchetti, R; Mancia, G; Grassi, G
Comparison between visit-to-visit office and 24-h blood pressure variability in treated hypertensive patients
2024 Mancia, G; Facchetti, R; Quarti-Trevano, F; Dell'Oro, R; Cuspidi, C; Grassi, G
New Guidelines for Hypertension Diagnosis and Treatment: An European Perspective
2024 Grassi, G
Renal Denervation in End-Stage Renal Disease: Current Evidence and Perspectives
2024 Scalise, F; Quarti-Trevano, F; Toscano, E; Sorropago, A; Vanoli, J; Grassi, G
Do We Need New Electrocardiographic Criteria for Left Ventricular Hypertrophy? The Case of the Peguero–Lo Presti Criterion. A Narrative Review
2024 Faggiano, A; Gherbesi, E; Tadic, M; Carugo, S; Grassi, G; Cuspidi, C
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile